Healixa Stock Current Valuation
| EMOR Stock | USD 0.06 0 5.17% |
Valuation analysis of Healixa helps investors to measure Healixa's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Fairly Valued
Today
Please note that Healixa's price fluctuation is out of control at this time. Calculation of the real value of Healixa is based on 3 months time horizon. Increasing Healixa's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Healixa pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Healixa. Since Healixa is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Healixa Pink Sheet. However, Healixa's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0631 | Real 0.0588 | Hype 0.08 |
The intrinsic value of Healixa's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Healixa's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Healixa helps investors to forecast how Healixa pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Healixa more accurately as focusing exclusively on Healixa's fundamentals will not take into account other important factors: Healixa Company Current Valuation Analysis
Healixa's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Healixa has a Current Valuation of 0.0. This is 100.0% lower than that of the Healthcare sector and about the same as Health Information Services (which currently averages 0.0) industry. The current valuation for all United States stocks is 100.0% higher than that of the company.
Healixa Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Healixa's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Healixa could also be used in its relative valuation, which is a method of valuing Healixa by comparing valuation metrics of similar companies.Healixa is currently under evaluation in current valuation category among its peers.
Healixa Fundamentals
| Shares Outstanding | 77.99 M | |||
| Market Capitalization | 15.6 M |
About Healixa Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Healixa's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Healixa using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Healixa based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Healixa
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Healixa position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Healixa will appreciate offsetting losses from the drop in the long position's value.Moving against Healixa Pink Sheet
| 0.71 | HQY | HealthEquity | PairCorr |
| 0.71 | AVTE | Aerovate Therapeutics | PairCorr |
| 0.68 | SOFI | SoFi Technologies Aggressive Push | PairCorr |
| 0.68 | BAC | Bank of America Fiscal Year End 10th of January 2025 | PairCorr |
| 0.66 | PYPL | PayPal Holdings Aggressive Push | PairCorr |
The ability to find closely correlated positions to Healixa could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Healixa when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Healixa - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Healixa to buy it.
The correlation of Healixa is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Healixa moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Healixa moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Healixa can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Healixa Pink Sheet Analysis
When running Healixa's price analysis, check to measure Healixa's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Healixa is operating at the current time. Most of Healixa's value examination focuses on studying past and present price action to predict the probability of Healixa's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Healixa's price. Additionally, you may evaluate how the addition of Healixa to your portfolios can decrease your overall portfolio volatility.